ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The specialty chemical makers Arkema and Clariant are each divesting a business. France’s Arkema is selling its phosphorus derivatives business Febex, which posted $30 million in sales last year, to Belgium-based Prayon. Arkema’s phosphoric acid, sodium hypophosphite, and derivatives are used primarily in electronics and pharmaceuticals. Meanwhile, the Swiss chemical company Clariant will sell its North American oil exploration chemical business, which had revenue of $113 million last year, to the Indian chemical company Dorf Ketal.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X